Call for Papers on “Buying and Selling Health Care”

The Journal of Law, Medicine & Ethics plans to publish a symposium issue in Winter 2014 exploring ethical, legal, and clinical issues triggered by the increasing commercialization of health care in the United States. The symposium will address a variety of dynamics present in this quintessentially American medical marketplace, with a particular focus on how commercialism impacts practitioners, patients, and policy makers at all levels.

Papers from any perspective or disciplinary background and concerning any aspect of the “buying and selling of health care” are welcome.

Deadlines and submission instructions below the fold.

We are primarily interested in papers between 15 and 30 double-spaced pages in length, although longer papers will receive careful consideration.

Please submit an abstract by November 1, 2013. Decisions on abstracts will be made quickly, andcompleted papers will be due by February 7, 2014. All submitted papers will undergo additional review by anonymous peers prior to final acceptance.

Correspondence should be directed to the symposium co-chairs, Joshua E. Perry of Indiana University’s Kelley School of Business at joshperr@indiana.edu (812-856-0120) or Larry R. Churchill of Vanderbilt University’s Medical School at larry.churchill@vanderbilt.edu (615-936-3540).

Potential Topics Include:

  • Is the practice of medicine a profession with business-like features, or a business with unique service components? Does the answer to this question matter for patients or practitioners? If health care in the United States is ultimately understood as a business, in what ways is this business enterprise similar to or divergent from other business practices and industries?
  • Will the Affordable Care Act ultimately move health care delivery in the United States more in the direction of a market-driven, patient-as-consumer system, or in the direction of expanded government involvement, or in the direction of strengthening the professional service dimensions of health care?
  • In the broader context of what Relman termed (in 1980!) the “medical-industrial complex,” do the life science, medical device, and pharmaceutical industries have any greater ethical responsibilities than do other (non-health care related) business enterprises? Do health care insurance companies? Do government bureaucracies?
  • What ethical and legal issues are triggered by a physician’s employment arrangement or ownership interest(s) in health care organizations or services to which patients are referred for treatment?
  • What consequences flow from the increasing adoption by hospitals, hospices, and other health care providers of for-profit organizational structures and aggressive marketing strategies?
  • What ethical and legal issues are raised by contemporary trends such as concierge medicine, physician entrepreneurialism, and medical tourism?
  • How should health care providers resolve economic or business concerns, i.e., decisions about costs, payments, insurance reimbursement, hospital budgets, etc. that impact on the delivery of clinical care to patients? How should health care managers and executives resolve these conflicts?
This entry was posted in Call for Abstracts, Conflicts of Interest, Doctor-Patient Relationship, Health Care Finance, Health Care Reform, Health Law Policy, Market Design by crobertson. Bookmark the permalink.

About crobertson

Christopher Robertson is a professor at the James E. Rogers College of Law, University of Arizona, and affiliated faculty with the Petrie Flom Center for Health Care Policy, Bioethics and Biotechnology at Harvard. Robertson also leads the Regulatory Science program, a partnership with the Arizona Health Sciences Center and the Critical Path Institute. Professor Robertson's research focuses on how the law can improve decisions by individuals and institutions -- attending to informational limits, conflicting interests, and cognitive biases, especially in the domain of healthcare. Blending legal, philosophical, and empirical methods, Robertson's work has been published in the New England Journal of Medicine, New York University Law Review, Cornell Law Review, Emory Law Journal, and the Journal of Empirical Legal Studies. He has received research support from the Robert Wood Johnson Foundation, and runs the Law and Behavior Research Lab at the University of Arizona. Robertson graduated magna cum laude from Harvard Law School, where he also served as a Petrie Flom fellow and lecturer. He earned a doctorate in Philosophy at Washington University in St. Louis, where he also taught bioethics. For 2013-2014, he was a visiting professor at Harvard Law School, and will visit at NYU School of Law in 2016-2017. Robertson's legal practice has focused on complex litigation involving medical and scientific disputes.